During the past decade, Celestino Sardu conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Celestino Sardu" are "Cardiac Death" (1 trials), "Congestive Heart Failure" (1 trials), "Heart Failure" (1 trials) and "Heart Failure With Reduced Ejection Fraction" (1 trials). Many other conditions were trialed in "Celestino Sardu" in a lesser frequency.

Most popular intervention types in "Celestino Sardu" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "echocardiographic optimization of CRTd" (1 trials) and "stem cells infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Celestino Sardu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Celestino Sardu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Celestino Sardu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Celestino Sardu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".